These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20549480)

  • 1. [Methods and means for pigmentation and depigmentation. Sense or nonsense?].
    Hegyi V; Hegyi J
    Hautarzt; 2010 Jul; 61(7):586-92. PubMed ID: 20549480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of light-induced hyperpigmentation of the skin with hydroquinone monobenzyl ester].
    Lur'e VG; Lur'e IV
    Vestn Dermatol Venerol; 1968 Feb; 42(2):84-6. PubMed ID: 5741236
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review.
    Kang HY; Valerio L; Bahadoran P; Ortonne JP
    Am J Clin Dermatol; 2009; 10(4):251-60. PubMed ID: 19489658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical chemotherapy of pigment abnormalities in surgical patients.
    Gilchrest BA; Goldwyn RM
    Plast Reconstr Surg; 1981 Apr; 67(4):435-9. PubMed ID: 7208685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new formula for depigmenting human skin.
    Kligman AM; Willis I
    Arch Dermatol; 1975 Jan; 111(1):40-8. PubMed ID: 1119822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone).
    McGuinn KP; Saedi N; Green JB; Dover JS
    Dermatol Surg; 2019 May; 45(5):756-757. PubMed ID: 30893165
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical use of hydroquinone for depigmentation.
    Spencer MC
    JAMA; 1965 Nov; 194(9):962-4. PubMed ID: 5897964
    [No Abstract]   [Full Text] [Related]  

  • 8. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
    Ladizinski B; Mistry N; Kundu RV
    Dermatol Clin; 2011 Jan; 29(1):111-23. PubMed ID: 21095535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hyperpigmentations of the skin with hydroguinone (depigmentation ointment)].
    Peisert E; Król C
    Przegl Dermatol; 1972; 59(2):205-9. PubMed ID: 5023356
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of a pigmented lesion induced by a Pelagia noctiluca sting.
    Kokelj F; Burnett JW
    Cutis; 1990 Jul; 46(1):62-4. PubMed ID: 1974491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depigmentation with tert-butyl hydroquinone using black guinea pigs.
    Patrick E; Juberg DR; O'Donoghue J; Maibach HI
    Food Chem Toxicol; 1999; 37(2-3):169-75. PubMed ID: 10227740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aesthetic problems associated with the cosmetic use of bleaching products.
    Ly F; Soko AS; Dione DA; Niang SO; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Int J Dermatol; 2007 Oct; 46 Suppl 1():15-7. PubMed ID: 17919199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation.
    Cook-Bolden FE; Hamilton SF
    Cutis; 2008 Apr; 81(4):365-71. PubMed ID: 18491487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Safety and Efficacy of Treatment With a 1,927-nm Diode Laser With and Without Topical Hydroquinone for Facial Hyperpigmentation and Melasma in Darker Skin Types.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Fabi SG
    Dermatol Surg; 2018 Oct; 44(10):1304-1310. PubMed ID: 29659405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cosmetic and dermatology: bleaching creams.
    Engasser PG; Maibach HI
    J Am Acad Dermatol; 1981 Aug; 5(2):143-7. PubMed ID: 7021611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tretinoin, hydroquinone, and betamethasone valerate in the therapy of melasma.
    Gano SE; Garcia RL
    Cutis; 1979 Feb; 23(2):239-41. PubMed ID: 421493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Topical treatment of hyperpigmentation disorders].
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S102-7. PubMed ID: 23260517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?
    Tse TW
    J Dermatolog Treat; 2010 Sep; 21(5):272-5. PubMed ID: 20095963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in the treatment of hyperpigmentation of facial skin with hydroquinone monobenzyl ether].
    Gusarova AS; Zalem ZIa
    Vestn Dermatol Venerol; 1966 Mar; 40(3):49-52. PubMed ID: 5988245
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.
    Draelos ZD; Yatskayer M; Bhushan P; Pillai S; Oresajo C
    Cutis; 2010 Sep; 86(3):153-8. PubMed ID: 21049734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.